Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results

Abstract

BackgroundNormal tension glaucoma (NTG) is commonly treated with anti-glaucoma medications. Recently, selective laser trabeculoplasty (SLT) has been demonstrated to lower the intraocular pressure (IOP) and medication use in NTG. The purpose of this study was to investigate the efficacy of a single session of SLT for NTG at 1 year.MethodsThis prospective cohort study recruited NTG patients taking anti-glaucoma medication. Potential subjects were excluded if they had had previous glaucoma surgery or laser and also if intraocular surgery or additional SLT procedures were performed after the first treatment. All subjects underwent a 1-month washout. A 30% IOP reduction was set as the target IOP. A single session of SLT was performed to 360 degrees of the trabecular meshwork. At 1-month after SLT, medication was resumed to achieve the target IOP. The IOP was measured every 3 months, and the number of medications was recorded at 3, 6, and 12 months. Only the right eye was used for statistical analysis.ResultsIn 41 right eyes, the mean pre-study IOP was 14.3 ± 3.4 mmHg while on 1.5 ± 0.8 eye drops. The post-washout IOP was 16.2 ± 2.2 mmHg. A mean of 191.1 ± 26.3 SLT shots at 1.0 ± 0.07 mJ were applied. There was significant IOP reduction at all time intervals following SLT when compared to the post-washout IOP (P < 0.0001). The number of medications was significantly reduced at all time intervals following SLT when compared to the pre-study level (P < 0.0001). At 12 months, the mean IOP was 12.2 ± 2.2 mmHg while on 1.1 ± 0.9 eye drops.ConclusionsA single session of SLT for NTG achieved an additional 15% IOP reduction while using 27% less medication at 1 year compared to pre-study levels.Trial registrationThe Clinical Trials Register of the University of Hong Kong HKCTR1847The European Clinical Trials Database 2014-003305-15 (August 11, 2014) (https://www.clinicaltrialsregister.eu/ctr-search/search?query=2014-003305-15)

A review of selective laser trabeculoplasty in the Hong Kong Chinese population

“…14,15 The Collaborative Normal-Tension Glaucoma Study Group has demonstrated that a 30% IOP reduction may slow disease progression of NTG despite a non-pressure dependent, hypoperfusion element in the disease pathophysiology. 16 Lee et al 6,17 prospectively treated 46 patients with NTG who were currently prescribed topical anti-glaucoma medications. They received a 1-month washout of medication and a single session of SLT before medications were gradually resumed in a step-wise manner.…”

Intense pulsed light for evaporative dry eye disease

“…DED is mostly age related,1 but can also be triggered by refractive3,4 or cataract surgery 5–7. In addition, preexisting DED significantly increases the risk of prolonged or severe post-op signs and symptoms of dry eye 8,9. Refractive and cataract surgery patients have high visual expectations, and increasingly sophisticated intraocular lens and corneal ablation designs heighten the importance of good ocular surface health.…”

Multi-scale Modeling of Vision-Guided Remodeling and Age-Dependent Growth of the Tree Shrew Sclera During Eye Development and Lens-Induced Myopia

“…McBrien and Norton [78] have shown that preventing natural collagen crosslinking alone does not alter the refractive development but doubles the axial elongation rate when used together with form deprivation in juvenile tree shrews. A recent study by Wang and Corpuz [79] has shown that artificial crosslinking using genipin slows myopia development in guinea pig. These two experimental observations support the notion that collagen crosslinks modulate the maximum scleral remodeling rate.…”